PPIs Could Raise Chronic Kidney Disease Risk
Jeannette Y. Wick, RPh, MBA, FASCP
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
Allison Gilchrist, Associate Editor
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Krystle Vermes
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Meghan Ross, Senior Associate Editor
Pharmacists are essential players in preventing and stopping the spread of influenza.
Rachel Lutz
Zinc supplementation in older patients could help boost their immunity.
Meghan Ross, Senior Associate Editor
The FDA today announced that it's taking a hard look at how it's addressing the opioid abuse epidemic.
Meghan Ross, Senior Associate Editor
A pharmacy robber was found dead in a van just 3 hours after he stole fentanyl.
Jeannette Y. Wick, RPh, MBA, FASCP
More than 20,000 articles have been written on how poor medication adherence, which costs the United States between $68 to $146 billion annually, increases adverse clinical outcomes and mortality.

Association News

The House Energy and Commerce Committee today held Congress’ first oversight hearing since the enactment of the Biologics Price Competition and Innovation Act in 2010.
The National Community Pharmacists Association and the Iowa Pharmacy Association have filed an amicus curiae brief in the United States Court of Appeals for the Eighth Circuit in support of the state of Iowa and against a challenge by the Pharmaceutical Care Management Association to the state’s MAC transparency law.
ASHP and the American Pharmacists Association today approved the new standard for PGY1 Community-based Pharmacy Residency Programs.
Increased transparency into the business practices and potential conflicts of interests of pharmacy benefit manager corporations could provide tangible benefits to payers, patients and pharmacists, the National Community Pharmacists Association said in comments submitted to the House Committee on Oversight and Government Reform, which held a hearing today on the prescription drug market.
Today the Campaign for Sustainable Rx Pricing announced that ASHP has officially joined the coalition.

Pharmacy Market News

Allergan has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.
Johnson & Johnson has announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action announced at the World Economic Forum in Davos, Switzerland.

Strategic Alliance Partner News

AmerisourceBergen Corporation and Publix have announced a long-term agreement encompassing the distribution of branded, generic and over-the-counter health and pharmaceutical products.
For hospitals considering enrollment in the Federal 340B Drug Pricing Program, the Health Resources and Services Administration's recent Omnibus Guidance could have significant impact on plans and operations.
Latest Issues